Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis
- PMID: 32428528
- DOI: 10.1016/j.jaci.2020.04.055
Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases